[go: up one dir, main page]

BRPI0821921A2 - Derivados de piripiropeno tendo uma atividade inibidora da acat2 - Google Patents

Derivados de piripiropeno tendo uma atividade inibidora da acat2

Info

Publication number
BRPI0821921A2
BRPI0821921A2 BRPI0821921-4A BRPI0821921A BRPI0821921A2 BR PI0821921 A2 BRPI0821921 A2 BR PI0821921A2 BR PI0821921 A BRPI0821921 A BR PI0821921A BR PI0821921 A2 BRPI0821921 A2 BR PI0821921A2
Authority
BR
Brazil
Prior art keywords
inhibitory activity
pyripyropene derivatives
acat2
acat2 inhibitory
pyripyropene
Prior art date
Application number
BRPI0821921-4A
Other languages
English (en)
Inventor
Hiroshi Tomoda
Tohru Nagamitsu
Satoshi Omura
Lee Rudel Lawrence
Original Assignee
Kitasato Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst filed Critical Kitasato Inst
Publication of BRPI0821921A2 publication Critical patent/BRPI0821921A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0821921-4A 2007-12-25 2008-12-17 Derivados de piripiropeno tendo uma atividade inibidora da acat2 BRPI0821921A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007331444 2007-12-25
PCT/JP2008/073501 WO2009081957A1 (ja) 2007-12-25 2008-12-17 Acat 2 阻害活性を有するピリピロペン誘導体

Publications (1)

Publication Number Publication Date
BRPI0821921A2 true BRPI0821921A2 (pt) 2015-06-16

Family

ID=40801257

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821921-4A BRPI0821921A2 (pt) 2007-12-25 2008-12-17 Derivados de piripiropeno tendo uma atividade inibidora da acat2

Country Status (7)

Country Link
US (1) US8519128B2 (pt)
EP (1) EP2228376B1 (pt)
JP (1) JP5479110B2 (pt)
CN (1) CN101965352A (pt)
BR (1) BRPI0821921A2 (pt)
CA (1) CA2710791A1 (pt)
WO (1) WO2009081957A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010150739A1 (ja) * 2009-06-23 2010-12-29 学校法人北里研究所 Acat2阻害活性を示す水酸基含有ピリピロペン誘導体
CA2795064A1 (en) 2010-03-31 2011-10-06 School Juridical Person Kitasato Institute Pyripyropene derivative having acat2 inhibiting activity and stable to metabolizing enzymes
US20130131091A1 (en) 2010-05-24 2013-05-23 Kimihiko Goto Harmful organism control agent
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN103536922B (zh) * 2012-07-13 2017-05-03 中国科学院上海生命科学研究院 酰基辅酶a:胆固醇酰基转移酶‑2抑制剂在抑制肝癌生长中的应用
JP2014144922A (ja) * 2013-01-28 2014-08-14 Kitasato Institute Acat2阻害活性を示すピリピロペンa構造簡略型誘導体
WO2015065595A1 (en) 2013-10-30 2015-05-07 Trustees Of Dartmouth College Method for selectively inhibiting acat1 in the treatment of obesity, metabolic syndrome, and atherosclerosis
JP5946100B2 (ja) * 2014-06-24 2016-07-05 学校法人北里研究所 コレステロールアシル転移酵素アイソザイム2(acat2)阻害活性を有する新規医薬化合物
KR102502031B1 (ko) 2016-11-16 2023-02-20 퍼듀 리서치 파운데이션 체중 및 대사 증후군을 조절하기 위한 조성물 및 방법
CN110950881A (zh) * 2018-09-27 2020-04-03 中国科学院上海药物研究所 一类三环类似物、其制备方法和用途
CN115052598A (zh) * 2020-01-27 2022-09-13 学校法人北里研究所 前蛋白转化酶枯草溶菌素/Kexin 9型(PCSK9)抑制剂及其药物用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3233476B2 (ja) * 1992-10-22 2001-11-26 社団法人北里研究所 Fo−1289物質およびその製造法
JP3725198B2 (ja) 1995-03-27 2005-12-07 社団法人北里研究所 ピリピロペン誘導体
JPH08269065A (ja) * 1995-04-03 1996-10-15 Kitasato Inst:The ピリピロペン誘導体
DE102004036689A1 (de) 2004-07-28 2006-03-23 Henkel Kgaa Rückstandsarmer Deodorant- oder Antitranspirant-Stift auf Basis einer Öl-in-Wasser-Dispersion
TWI388282B (zh) * 2005-06-01 2013-03-11 Meiji Seika Pharma Co Ltd 害蟲控制劑

Also Published As

Publication number Publication date
US8519128B2 (en) 2013-08-27
WO2009081957A1 (ja) 2009-07-02
EP2228376B1 (en) 2015-06-03
EP2228376A1 (en) 2010-09-15
JPWO2009081957A1 (ja) 2011-05-06
JP5479110B2 (ja) 2014-04-23
EP2228376A4 (en) 2011-10-19
US20110184173A1 (en) 2011-07-28
CN101965352A (zh) 2011-02-02
CA2710791A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
BRPI0821921A2 (pt) Derivados de piripiropeno tendo uma atividade inibidora da acat2
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
DK2134708T3 (da) 3-Cyano-4-(4-tetrahydropyranphenyl)-pyridin-2-on-derivater
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
BRPI0906495A2 (pt) Derivados de indolol-piridona tendo atividade inibidora de quinase de ponto de checagem 1
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0817935A2 (pt) Derivados de biarila
BRPI0821947A2 (pt) derivados de antibiótico de glicopetídeo glicosilatado
BRPI0720220A2 (pt) Derivados de quinolinas antibacterianos
ATE483711T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
BRPI0814236A2 (pt) Derivados de quinazolinamida
ATE512135T1 (de) Spiroindolinonderivate
FR20C1027I2 (fr) Derives de tiglien-3-one
BRPI0807087A2 (pt) Inibidores de hcv macrocíclicos substituídos de pirimidina
BRPI0812518A2 (pt) Derivados de indazolamida
DK2035394T3 (da) 2-pyrazincarboxamidderivater
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
CR10562A (es) Nuevos derivados de piridazina
BRPI0920183A2 (pt) derivados de fenetilamida e seus analogos heterociclicos
BRPI0719879A2 (pt) Derivados de hidrobenzamida como inibidores de hsp90
CR10809A (es) Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.